Adefovir Dipivoxil supplier & exporter
Product Description
API name | Adefovir Dipivoxil |
CAS Number | 142340-99-6 |
Therapeutic Category | Antiviral |
Route of Administration | Tablet |
Regulatory Documents | TECH PACK, DMF |
Trader & Wholesaler of Adefovir Dipivoxil
Mechanism of Action:
Adefovir dipivoxil is a prodrug of adefovir. Adefovir is an acyclic nucleotide analog of adenosine monophosphate which is phosphorylated to the active metabolite adefovir diphosphate by cellular kinases. Adefovir diphosphate inhibits HBV DNA polymerase (reverse transcriptase) by competing with the natural substrate deoxyadenosine triphosphate and by causing DNA chain termination after its incorporation into viral DNA.
Drug Indications:
Indicated for the treatment of chronic hepatitis B in adult patients with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease; this is based on histological, virological, biochemical, and serological responses in adult patients with HBeAg+ and HBeAg- chronic hepatitis B with compensated liver function, and in adult patients with clinical evidence of lamivudine-resistant hepatitis B virus with either compensated or decompensated liver function.